TRICYCLIC FUSED PYRIMIDINE COMPOUNDS AS INHIBITORS OF p97 COMPLEX
申请人:Cleave Biosciences, Inc.
公开号:US20170267679A1
公开(公告)日:2017-09-21
Tricyclic fused pyrimidine compounds having an arylalkyl amine substituent at the P4 position and a substituted 1H-indol-1-yl, 1H-indol-3-yl, indanyl, indazol-1-yl, indazol-3-yl, benzotriazol-1-yl or 1H-benz[d]imidazol-1-yl group at the P2 position well as optional aliphatic, functional and/or aromatic components substituted at other positions of the tricyclic compounds of the invention. These compounds are inhibitors of the AAA proteasome complex containing p97 and are effective medicinal agents for treatment of diseases associated with p97 bioactivity such as cancer.
[EN] TRANSTHYRETIN STABILIZING COMPOUNDS<br/>[FR] COMPOSÉS STABILISATEURS DE TRANSTHYRÉTINE
申请人:[en]PROTEGO BIOPHARMA, INC.
公开号:WO2023009585A2
公开(公告)日:2023-02-02
Provided herein are compounds having activity against TTR related conditions, and pharmaceutically accepted salts and solvates thereof. Also provided are methods of using the compounds for inhibiting and preventing TTR aggregation and/or amyloid formation in the peripheral nerves, kidney, cardiac tissue, eye and CNS, and of treating a subject with peripheral TTR amyloidosis.
Structure–antiproliferative activity studies on<scp>l</scp>-proline- and homoproline-4-N-pyrrolidine-3-thiosemicarbazone hybrids and their nickel(<scp>ii</scp>), palladium(<scp>ii</scp>) and copper(<scp>ii</scp>) complexes
作者:Aliona Dobrova、Sonja Platzer、Felix Bacher、Miljan N. M. Milunovic、Anatolie Dobrov、Gabriella Spengler、Éva A. Enyedy、Ghenadie Novitchi、Vladimir B. Arion
DOI:10.1039/c6dt02784a
日期:——
metal complexes 1–4 was studied in three human cancer cell lines (A549, CH1 and SW480) and in noncancerous murine embryonal fibroblasts (NIH/3T3), and the mechanism of cell death was also assayed by flow cytometry. Clear-cut structure–activity relationships have been established. The metal ions exert marked effects in a divergent manner: copper(II) increases, whereas nickel(II) and palladium(II) decrease
合成了两个水溶性的硫代半碳素-脯氨酸(H 2 L 1)和硫代半碳胺-高脯氨酸杂种(H 2 L 2)。通过H 2 L 1与NiCl 2 ·6H 2 O,PdCl 2和CuCl 2 ·2H 2 O在乙醇中的反应,形成一系列方形平面络合物[Ni(H 2 L 1)Cl] Cl·1.3H 2 O (1 ·1.3H 2 O),[Pd(H 2 L 1)Cl] Cl·H 2 O(2 ·H 2 O)和[Cu(H制备了2 L 1)Cl] Cl·0.7H 2 O( 3 ·0.7H 2 O),并从甲醇中的H 2 L 2和CuCl 2 ·2H 2 O开始,络合物[Cu(H 2 L 2)获得Cl 2 ]·H 2 O( 4 ·H 2 O)。所述化合物已经通过元素分析,光谱法(IR,UV-vis和NMR光谱法),ESI质谱和单晶X射线晶体学(H 2大号1, 1, 2和4)。作为固体,1是抗磁性的,而在甲醇溶液中则是顺磁性的。室温下3